Procter & Gamble
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Procter & Gamble's revenues will grow 1.7% and EPS will compress -4.9%.
The average estimate for revenue is $20.55 billion. On the bottom line, the average EPS estimate is $0.78.
Last quarter, Procter & Gamble booked revenue of $20.60 billion. GAAP reported sales were 2.0% higher than the prior-year quarter's $20.19 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.99. GAAP EPS of $0.88 for Q3 were 7.3% higher than the prior-year quarter's $0.82 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 50.1%, 80 basis points better than the prior-year quarter. Operating margin was 17.4%, 100 basis points better than the prior-year quarter. Net margin was 12.5%, 60 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $84.23 billion. The average EPS estimate is $4.04.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 7,421 members out of 7,676 rating the stock outperform, and 255 members rating it underperform. Among 1,963 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,925 give Procter & Gamble a green thumbs-up, and 38 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Procter & Gamble is outperform, with an average price target of $78.61.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Procter & Gamble. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Procter & Gamble to My Watchlist.